Limiting the development of anti-cancer drug resistance in a spatial model of micrometastases (Q326548): Difference between revisions

From MaRDI portal
Importer (talk | contribs)
Created a new Item
 
ReferenceBot (talk | contribs)
Changed an Item
 
(6 intermediate revisions by 5 users not shown)
Property / Mathematics Subject Classification ID
 
Property / Mathematics Subject Classification ID: 92C50 / rank
 
Normal rank
Property / Mathematics Subject Classification ID
 
Property / Mathematics Subject Classification ID: 37N25 / rank
 
Normal rank
Property / zbMATH DE Number
 
Property / zbMATH DE Number: 6637662 / rank
 
Normal rank
Property / zbMATH Keywords
 
maximum tolerated dose
Property / zbMATH Keywords: maximum tolerated dose / rank
 
Normal rank
Property / zbMATH Keywords
 
metronomic chemotherapy
Property / zbMATH Keywords: metronomic chemotherapy / rank
 
Normal rank
Property / zbMATH Keywords
 
fractionated therapy
Property / zbMATH Keywords: fractionated therapy / rank
 
Normal rank
Property / zbMATH Keywords
 
chemoresistance
Property / zbMATH Keywords: chemoresistance / rank
 
Normal rank
Property / zbMATH Keywords
 
micrometastases
Property / zbMATH Keywords: micrometastases / rank
 
Normal rank
Property / zbMATH Keywords
 
hybrid model
Property / zbMATH Keywords: hybrid model / rank
 
Normal rank
Property / MaRDI profile type
 
Property / MaRDI profile type: MaRDI publication profile / rank
 
Normal rank
Property / OpenAlex ID
 
Property / OpenAlex ID: W2962732437 / rank
 
Normal rank
Property / Wikidata QID
 
Property / Wikidata QID: Q38738084 / rank
 
Normal rank
Property / arXiv ID
 
Property / arXiv ID: 1601.03412 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers / rank
 
Normal rank
Property / cites work
 
Property / cites work: A stochastic model for the origin and treatment of tumors containing drug-resistant cells / rank
 
Normal rank
Property / cites work
 
Property / cites work: Evolution of resistance to anti-cancer therapy during general dosing schedules / rank
 
Normal rank
Property / cites work
 
Property / cites work: Emergence of Anti-Cancer Drug Resistance: Exploring the Importance of the Microenvironmental Niche via a Spatial Model / rank
 
Normal rank
Property / cites work
 
Property / cites work: The impact of cell density and mutations in a model of multidrug resistance in solid tumors / rank
 
Normal rank
Property / cites work
 
Property / cites work: A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy / rank
 
Normal rank
Property / cites work
 
Property / cites work: Stochastic modeling of cellular colonies with quiescence: an application to drug resistance in cancer / rank
 
Normal rank
Property / cites work
 
Property / cites work: Dynamics and control of a mathematical model for metronomic chemotherapy / rank
 
Normal rank
Property / cites work
 
Property / cites work: Drug resistance in cancer chemotherapy as an optimal control problem / rank
 
Normal rank
Property / cites work
 
Property / cites work: On the MTD paradigm and optimal control for multi-drug cancer chemotherapy / rank
 
Normal rank
Property / cites work
 
Property / cites work: Modeling the effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors / rank
 
Normal rank
Property / cites work
 
Property / cites work: Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies / rank
 
Normal rank
links / mardi / namelinks / mardi / name
 

Latest revision as of 16:53, 12 July 2024

scientific article
Language Label Description Also known as
English
Limiting the development of anti-cancer drug resistance in a spatial model of micrometastases
scientific article

    Statements

    Limiting the development of anti-cancer drug resistance in a spatial model of micrometastases (English)
    0 references
    0 references
    0 references
    0 references
    12 October 2016
    0 references
    maximum tolerated dose
    0 references
    metronomic chemotherapy
    0 references
    fractionated therapy
    0 references
    chemoresistance
    0 references
    micrometastases
    0 references
    hybrid model
    0 references

    Identifiers